| Deborah Ann Syren-vitullo, PHD | |
|
5905 Soquel Dr, Suite 600, Soquel, CA 95073-2855 | |
| (831) 332-3555 | |
| Not Available |
| Full Name | Deborah Ann Syren-vitullo |
|---|---|
| Gender | Female |
| Speciality | Psychologist |
| Location | 5905 Soquel Dr, Soquel, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447459219 | NPI | - | NPPES |
| PSY14934 | Other | CA | BOARD OF PSYCHOLOGY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | PSY14934 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Deborah Ann Syren-vitullo, PHD 5905 Soquel Dr, Suite 600, Soquel, CA 95073-2855 Ph: (831) 332-3555 | Deborah Ann Syren-vitullo, PHD 5905 Soquel Dr, Suite 600, Soquel, CA 95073-2855 Ph: (831) 332-3555 |
News Archive
The results of a study involving more than 9,000 patients, presented today at the European League Against Rheumatism Annual Congress showed that Type 1 diabetes occurs significantly more frequently in patients with Juvenile Inflammatory Arthritis (JIA) than in the general population.
Inspired by promising tests of web-based health intervention measures, the researchers aimed to find out whether the risk of developing depression could be reduced by a six-week online training course called GET.ON. GET.ON is based on established therapy methods involving systematic problem solving and behavioural activation.
Alaska Northern Lights manufactures a bright light therapy box that aids in treating chronic health problems such as seasonal affective disorder (SAD), depression, bipolar disorder and sleep problems. Sufferers of SAD, a form of clinical depression, include up to 25 percent of those living in northern latitudes who experience varying degrees of SAD during winter months when there is less natural light. Night shift workers are also susceptible to SAD which affects over one third of the population, or about 10.8 million Americans.
Eisai Inc. today announced that it has submitted simultaneous regulatory applications for approval of eribulin mesylate (also known as E7389) for the treatment of locally advanced or metastatic breast cancer to agencies in Japan, the United States and the European Union (EU). Eribulin, a non-taxane microtubule dynamics inhibitor, is an investigational chemical compound discovered and developed by Eisai.
› Verified 4 days ago
Dr. Randolph F Brock, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3121 Park Ave, Suite I, Soquel, CA 95073 Phone: 954-647-8077 | |
Lorraine Kay Butterworth, MED, MA, PSYD ASSOC. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4630 Soquel Dr Ste 10, Soquel, CA 95073 Phone: 831-239-2015 | |
Dr. Leah Louanne Ellison Cole, PH D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 5905 Soquel Dr, 600, Soquel, CA 95073 Phone: 831-479-9690 Fax: 831-479-9690 | |
Dr. Amy Irene Gregg, PH.D., M.A. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 5905 Soquel Dr, Ste 500, Soquel, CA 95073 Phone: 831-655-4030 | |
Marianna Jane Gabriel Mejia, MFT Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1009 Hidden Valley Rd, Soquel, CA 95073 Phone: 831-477-2818 Fax: 831-477-2818 | |
Greg Hajcak, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2901 Park Ave Ste D8, Soquel, CA 95073 Phone: 831-222-0648 |